Distribution agreement with Beckman Coulter Life Sciences for COVID-19 PCR testing
Dr Hugo Stephenson, CEO of Induction Healthcare Group PLC (INHC.L) Interview
Dr Hugo Stephenson, Joint-CEO of Induction Healthcare, said: The Group has generated excellent commercial momentum in the first half of the current financial year and has delivered its first full
Genedrive PLC (GDR.L) 96 SARS CoV-2 Kit able to detect all published virus strains
Genedrive plc (AIM: GDR), the near-patient molecular diagnostics company, confirms that its Genedrive 96 SARS CoV-2 Kit continues to detect all known variants of COVID-19, including the newest variants released
Genedrive PLC (GDR.L) Notification of intent to distribute in the USA
Genedrive notifies FDA of its intent to distribute to SARS-CoV-2 PCR test in the USA
Genedrive PLC (GDR.L) HCV ID Kit demonstrates high clinical accuracy in India study
Hepatitis C virus testing kit reveals 100% sensitivity and specificity when compared to Abbott Realtime HCV test
Genedrive PLC (GDR.L) Notice of Results
genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces that it will release its financial results for the year ended 30 June 2020 on Tuesday 17 November 2020.
Genedrive PLC (GDR.L) Point-of-Care solution to detect SARS-CoV-2 virus
Genedrive plc (LSE: GDR), the near patient molecular diagnostics company, announces it has completed the assay design for the Company’s Point-of-Care (“POC”) solution for COVID-19 testing and is now generating
Genedrive PLC (GDR.L) Verification with Beckman Coulter Life Sciences
Genedrive® 96 SARS-CoV-2 Kit verified with Beckman Coulter Life Sciences RNA extraction chemistry
Genedrive PLC (GDR.L) Collaboration to automate COVID-19 PCR testing
Beckman Coulter collaboration to automate high throughput SARS-CoV-2 PCR testing
TPI provides its latest research note on Avacta Group plc (AVCT.L).
Avacta has announced that collaborative work with the Centre for Virus Research at the University of Glasgow.
TPI provides its latest research note on Avacta Group plc (AVCT.L).
Avacta has announced that the BAMSTM diagnostic test for the COVID-19 infection being developed with its partner Adeptrix (Beverly MA, USA).
David Budd, Chief Executive Officer of Genedrive PLC (GDR.L) Podcast
Share Talk caught up with Manchester-based company Genedrive PLC and spoke with David Budd, CEO about the company recent announcement with the development of two coronavirus tests, one for central